Clinical Trial Update: Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating trilaciclib for efficacy, safety, and pharmacokinetics in extensive-stage small cell lung cancer has completed and results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Cosela (trilaciclib)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Extensive-stage Small-cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-07-10